Making essential medicines available in developing countries is a pressing international problem. Behind the humanitarian urgency lie longer-term economic, cultural and even geopolitical challenges.
Following up on The Economics of Essential Medicines (2002), this volume extends the debate on the best practical ways of improving access to health care and the delivery of health services. While there have been encouraging signs of increased attention to these issues by public policy-makers in rich countries - such as the recent EU initiative to allow the export of generic drugs to poor countries - huge unsolved problems remain. These are addressed by a wide range of contributors - academics and policy-makers from both rich and poor countries, alongside representatives of NGOs and the pharmaceutical sector. Through a combination of detailed thematic and case studies, this volume aims to show the most promising ways forward to ensure essential medicines become accessible to all.
'This timely book edited by two extremely competent writers in this field will make a substantially valuable contribution to an area that could make a significant impact on the health of the most vulnerable. Highly recommended and extremely interesting reading.'
- Professor Nicky Padayachee, Dean of the Faculty of Health Sciences, Member of the Medicines Control Council and Chairperson of the Medical Deans Committee, University of Cape Town.
Amir Attaran is Associate Fellow, International Economics Programme, Chatham House, and Associate Professor, Faculty of Law and Institute for Population Health, Ottawa.
Brigitte Granville is Professor of International Economics and Economic Policy, Centre for Business Management, Queen Mary, University of London; formerly Head of the International Economics Programme, Chatham House.
Exclusive distribution worldwide by the Brookings Institution.